Artificial intelligence is generating enormous wealth, but who should benefit? OpenAI rival Anthropic wants to share some of its financial success with the public through a new fund aimed at addressing AI’s wider impact. Announced on October 18, the initiative could eventually direct a substantial portion of Claude developers’ ownership toward charitable and economic support programmes.
Donations tied to growth
Under the announcement, Anthropic plans to allocate 5% of its shares to the newly established Anthropic Public Benefit Fund, subject to shareholder approval. The commitment could grow further, with another 2% added at the board’s discretion whenever the company’s valuation increases by 50% above an undisclosed baseline.
Rather than establishing a traditional charity, the company will operate the fund through a wholly owned limited liability company. This structure allows greater flexibility when supporting nonprofit organisations or distributing financial assistance directly to affected communities.
The initiative builds on earlier commitments from Anthropic’s founders, who pledged 80% of their personal equity holdings to charitable causes. Approximately half of its employees participate in a programme matching their donated shares. Combined, these arrangements would dedicate roughly 20% of Anthropic’s equity to public benefit, excluding potential future increases.
AI job disruption takes priority
Beyond charitable donations, Anthropic hopes to address growing concerns about artificial intelligence replacing human workers. Its existing $200 million commitment to studying and tackling labour market disruption could eventually be complemented by more direct financial support. Already operating as a public benefit corporation, Anthropic conducts AI safety research, biomedical studies and discounted Claude services for nonprofits and scientific institutions.
However, the new fund will operate separately from these commercial activities, with its equity prohibited from financing political donations or lobbying anywhere in the world. More details about the fund’s governance, valuation milestones and oversight are expected in the coming months, alongside a public benefit report examining the company’s progress.
